Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial
Publication
, Conference
DeAngelo, DJ; Yin, J; Advani, AS; Luger, S; Fulcher, J; Liedtke, M; Uy, GL; Dinner, SN; Wilde, L; Luskin, MR; Saygin, C; Postich, E; Teske, R ...
Published in: Blood
November 5, 2024
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
308 / 308
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
DeAngelo, D. J., Yin, J., Advani, A. S., Luger, S., Fulcher, J., Liedtke, M., … Stock, W. (2024). Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial. In Blood (Vol. 144, pp. 308–308). American Society of Hematology. https://doi.org/10.1182/blood-2024-209438
DeAngelo, Daniel J., Jun Yin, Anjali S. Advani, Selina Luger, Jill Fulcher, Michaela Liedtke, Geoffrey L. Uy, et al. “Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial.” In Blood, 144:308–308. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-209438.
DeAngelo DJ, Yin J, Advani AS, Luger S, Fulcher J, Liedtke M, et al. Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial. In: Blood. American Society of Hematology; 2024. p. 308–308.
DeAngelo, Daniel J., et al. “Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 308–308. Crossref, doi:10.1182/blood-2024-209438.
DeAngelo DJ, Yin J, Advani AS, Luger S, Fulcher J, Liedtke M, Uy GL, Dinner SN, Wilde L, Luskin MR, Saygin C, Postich E, Fulton N, Harvey RC, Perez Burbano GE, Teske R, Erba HP, Litzow MR, Stone RM, Stock W. Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial. Blood. American Society of Hematology; 2024. p. 308–308.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
308 / 308
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology